AMY BRASHER: Open Payments
NPI 1922133966 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 58 payments from 17 companies in 2025. Trend: 2023 $2,053 · 2024 $1,345 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $184 |
| GlaxoSmithKline, LLC. | 12 | $181 |
| Axsome Therapeutics, Inc. | 6 | $135 |
| Lilly USA, LLC | 5 | $115 |
| Novo Nordisk Inc | 3 | $77 |
| Lundbeck LLC | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| ABBVIE INC. | 3 | $64 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
Products named: TRELEGY ELLIPTA, Auvelity, MOUNJARO, AIRSUPRA, FARXIGA, Wegovy, VYEPTI, Kerendia.
Industry payments across TX — which companies pay providers there.
